Chronic Pain

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

5 hours ago   |   Xconomy

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is...
Read more ...

The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors: a systematic review and meta-analysis

2 days ago   |   Springer

Abstract Background Evidence is mixed regarding the effect of exercise programs on improving musculoskeletal symptoms and quality of life. Previous meta-analyses have not...
Read more ...

Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran

3 days ago   |   Springer   |   2 articles

Abstract Hepatitis C virus infection is a serious global health problem and a cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Bioinformatics software...
Read more ...

Research shows the way to more efficient EPO production

4 days ago   |   Phys

To many people, EPO rhymes with doping and cycling. But in fact, EPO is an important medical drug. This hormone works naturally in the body by stimulating red blood cell...
Read more ...

Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain

4 days ago   |   San Diego Biotechnology

Updated Prescription Drug User Fee Act Goal Date Is June 26, 2020 - Contract Manufacturing Site for HTX-011 Reinspected by FDA with No Observations Issued and a Recommendation...
Read more ...

Vifor buys priority review voucher for vadadustat filing

6 days ago   |   Fierce Biotech   |   3 articles

Vifor Pharma has struck a deal to buy a priority review voucher. The PRV sets Vifor and partner Akebia Therapeutics up to benefit from a fast review at the FDA when they file...
Read more ...

Scripps Research's Calibr to Test “Switchable” CAR-T in Clinical Trial

Scripps Research's Calibr to Test “Switchable” CAR-T in Clinical Trial

17 days ago   |   Xconomy

Scripps Research is charting new territory with its Calibr division, a drug discovery and drug development group within the research institute that is advancing its own...
Read more ...

Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff

Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff

18 days ago   |   Xconomy

Merck is corralling products representing $6.5 billion in sales and spinning them off into a separate company , a strategic bet that focusing the remaining business on...
Read more ...

Putrid compound may have a sweet side gig as atherosclerosis treatment

19 days ago   |   ScienceDaily

A compound associated with the smell of death may have potential as a treatment for atherosclerosis and other chronic inflammatory diseases.
Read more ...

Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals

Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals

20 days ago   |   Xconomy   |   2 articles

Rare disease drug developer Insmed on Monday revealed data from a mid-stage trial of its daily pill for adults with non-cystic fibrosis bronchiectasis, a severe chronic...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...